Price Alert

Lixte Biotechnology Inc. (LIXT)

NASDAQ: LIXT · Real-Time Price · USD

3.56

-0.34 (-8.72%)

At close: Aug 15, 2025, 3:59 PM

3.62

1.69%

After-hours: Aug 15, 2025, 05:16 PM EDT

Lixte Biotechnology Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	887.21K	1.38M	1.04M	1.64M	2.6M	3.41M	4.2M	5.11M	2.91M	4.09M	5.35M	6.56M	7.74M	3.78M	4.82M	5.96M	6.8M	7.74M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	198.83K	n/a	n/a	6.93K	n/a	78.02K	78.02K	78.01K	78.02K	131.19K	147.02K	147.02K	147.02K	10.91K	150.24K	26.38K	323.33K	12.99K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	n/a	n/a	n/a	78.02K	27.84K	49.56K	56.1K	n/a	257.63K	40.56K	329.04K	10.25K	32.22K	44.87K	62.5K
Total Current Assets	989.75K	1.51M	1.15M	1.69M	2.67M	3.51M	4.31M	5.23M	3.1M	4.33M	5.56M	6.82M	8.02M	4.11M	5.09M	6.31M	7.24M	7.89M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	198.83K	n/a	n/a	6.93K	n/a	78.02K	78.02K	78.01K	78.02K	131.19K	147.02K	147.02K	147.02K	10.91K	150.24K	26.38K	323.33K	12.99K
Total Assets	1.19M	1.51M	1.15M	1.7M	2.67M	3.59M	4.31M	5.23M	3.1M	4.33M	5.56M	6.82M	8.02M	4.12M	5.09M	6.33M	7.24M	7.89M
Account Payables	92.15K	112.48K	83.21K	72.86K	131.4K	246.69K	120.51K	221.17K	366.53K	223.63K	183.75K	307.4K	337.02K	369.49K	225.97K	232.02K	162.45K	148.87K
Deferred Revenue	n/a	242.62K	235.08K	256.1K	290.06K	216.15K	157.1K	90.56K	36.09K	26.36K	165.02K	100.93K	158.83K	275.1K	76.96K	26.68K	213.88K	93.53K
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	444.97K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-970	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	537.12K	355.1K	318.28K	328.96K	421.46K	462.84K	313.86K	311.74K	402.61K	249.99K	394.79K	408.33K	531.54K	644.59K	302.93K	258.7K	376.33K	242.4K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	26.36K	394.79K	408.33K	n/a	275.1K	302.93K	n/a	n/a	n/a
Total Liabilities	537.12K	355.1K	318.28K	328.96K	421.46K	462.84K	313.86K	311.74K	402.61K	249.99K	394.79K	408.33K	531.54K	644.59K	302.93K	258.7K	376.33K	242.4K
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	276.00	268.00	225.00	225.00	225.00	225.00	225.00	225.00	166.00	1.67K	1.66K	1.66K	1.66K	1.37K	1.37K	1.37K	1.37K	1.35K
Retained Earnings	-53.55M	-52.78M	-52.07M	-51.45M	-50.46M	-49.45M	-48.48M	-47.45M	-46.43M	-44.76M	-43.39M	-41.76M	-40.29M	-38.74M	-37.08M	-35.05M	-33.81M	-32.08M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	-225	-225	-225	-166	n/a	0.00	n/a	0.00	0.00	n/a	n/a	0.00	n/a
Shareholders Equity	651.46K	1.16M	827.22K	1.37M	2.25M	3.13M	3.99M	4.92M	2.69M	4.08M	5.17M	6.41M	7.49M	3.47M	4.79M	6.07M	6.87M	7.65M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a